These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19484390)

  • 1. Quo vadis: whither homocysteine research?
    Joseph J; Handy DE; Loscalzo J
    Cardiovasc Toxicol; 2009 Jun; 9(2):53-63. PubMed ID: 19484390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and cardiovascular disease.
    Kalra DK
    Curr Atheroscler Rep; 2004 Mar; 6(2):101-6. PubMed ID: 15023293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of hyperhomocysteinemia and its pathological significance.
    Kim J; Kim H; Roh H; Kwon Y
    Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and Non-Cardiac Vascular Disease.
    Katsiki N; Perez-Martinez P; Mikhailidis DP
    Curr Pharm Des; 2017; 23(22):3224-3232. PubMed ID: 28317478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
    Shakhmatova OO; Komarov AL; Panchenko EP
    Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
    Tselmin S; Rodionov RN; Müller G; Bornstein S; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):123-8. PubMed ID: 23357153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
    Clarke R; Stansbie D
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):624-32. PubMed ID: 11732645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and vitamins in cardiovascular disease.
    Jacobsen DW
    Clin Chem; 1998 Aug; 44(8 Pt 2):1833-43. PubMed ID: 9702993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, cardiovascular inflammation, and myocardial remodeling.
    Finch JM; Joseph J
    Cardiovasc Hematol Disord Drug Targets; 2010 Dec; 10(4):241-5. PubMed ID: 20932268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interaction between Arachidonic Acid Metabolism and Homocysteine.
    Domi E; Hoxha M; Hoxha B; Zappacosta B
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1232-1241. PubMed ID: 32888285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
    Kang SS; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):233-240. PubMed ID: 29679304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for homocysteine in clinical practice.
    Nichols J
    Nutr Health; 2017 Mar; 23(1):13-15. PubMed ID: 28068865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.
    Debreceni B; Debreceni L
    Cardiovasc Ther; 2014 Jun; 32(3):130-8. PubMed ID: 24571382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and arterial thrombosis: Challenge and opportunity.
    Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease.
    McKinley MC
    Proc Nutr Soc; 2000 May; 59(2):221-37. PubMed ID: 10946791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine lowering and cardiovascular disease risk: lost in translation.
    Marcus J; Sarnak MJ; Menon V
    Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.